Cargando…

Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin

Myeloid-derived suppressor cells (MDSCs) constitute a key checkpoint that impedes tumor immunity against cancer. Chemotherapeutic intervention of MDSCs has gained ground as a strategy for cancer therapy but its mechanism remains obscure.We report here a unique mechanism by which monocytic (M)-MDSCs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Junmin, Donatelli, Sarah S., Gilvary, Danielle L., Tejera, Melba M., Eksioglu, Erika A., Chen, Xianghong, Coppola, Domenico, Wei, Sheng, Djeu, Julie Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942787/ https://www.ncbi.nlm.nih.gov/pubmed/27405665 http://dx.doi.org/10.1038/srep29521

Ejemplares similares

HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells
por: Zhou, Junmin, et al.
Publicado: (2015)

Inactivation of DAP12 in PMN Inhibits TREM1-Mediated Activation in Rheumatoid Arthritis
por: Chen, Xianghong, et al.
Publicado: (2015)

Immune evasion by TGFβ-induced miR-183 repression of MICA/B expression in human lung tumor cells
por: Trinh, Thu Le, et al.
Publicado: (2019)

MicroRNA-155 governs SHIP-1 expression and localization in NK cells and regulates subsequent infiltration into murine AT3 mammary carcinoma
por: Kandell, Wendy M., et al.
Publicado: (2020)

Bone Marrow Mononuclear Cells Up-Regulate Toll-Like Receptor Expression and Produce Inflammatory Mediators in Response to Cigarette Smoke Extract
por: Zhou, Junmin, et al.
Publicado: (2011)

Novel Therapeutic Approach to Improve Hematopoiesis in low risk MDS by Targeting MDSCs with The Fc-engineered CD33 Antibody BI 836858
por: Eksioglu, Erika A., et al.
Publicado: (2017)

Constitutively Activated DAP12 Induces Functional Anti-Tumor Activation and Maturation of Human Monocyte-Derived DC
por: Dalton, Robert, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer
por: Katoh, Hiroshi, et al.
Publicado: (2015)

Murine Pancreatic Adenocarcinoma Reduces Ikaros Expression and Disrupts T Cell Homeostasis
por: Nelson, Nadine, et al.
Publicado: (2015)

Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies
por: De Veirman, Kim, et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
por: Law, Andrew M. K., et al.
Publicado: (2020)

Clusterin is involved in mediating the metabolic function of adipose SIRT1
por: Zhang, Pengcheng, et al.
Publicado: (2021)

Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
por: Li, Kai, et al.
Publicado: (2021)

Clusterin induced by N,N′-Dinitrosopiperazine is involved in nasopharyngeal carcinoma metastasis
por: Li, Yuejin, et al.
Publicado: (2015)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma
por: Cheng, Pingyan, et al.
Publicado: (2022)

The role of Clusterin in cancer metastasis
por: Peng, Mei, et al.
Publicado: (2019)

Clusterin Expression in Colorectal Carcinomas
por: Téllez, Teresa, et al.
Publicado: (2023)

The Role and Potential Therapeutic Application of Myeloid-Derived Suppressor Cells in Allo- and Autoimmunity
por: Zhang, Qi, et al.
Publicado: (2015)

Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
por: Wesolowski, Robert, et al.
Publicado: (2013)

Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer
por: Ma, Jie, et al.
Publicado: (2018)

Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma
por: Won, Woong-Jai, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches
por: Thyagarajan, Anita, et al.
Publicado: (2019)

Therapeutic Values of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma: Facts and Hopes
por: Wang, Yijun, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells as Therapeutic Targets in Uterine Cervical and Endometrial Cancers
por: Mabuchi, Seiji, et al.
Publicado: (2021)

Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers
por: Fan, Rong, et al.
Publicado: (2022)

Myeloid-Derived Suppressor Cells in Sepsis
por: Lai, Dengming, et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells in Sepsis
por: Schrijver, Irene T., et al.
Publicado: (2019)

On the origin of myeloid-derived suppressor cells
por: Millrud, Camilla Rydberg, et al.
Publicado: (2016)

Myeloid-derived suppressor cells in gliomas
por: Gieryng, Anna, et al.
Publicado: (2016)

Astrocyte-derived clusterin suppresses amyloid formation in vivo
por: Wojtas, Aleksandra M., et al.
Publicado: (2020)

Therapeutic Potential of the Molecular Chaperone and Matrix Metalloproteinase Inhibitor Clusterin for Dry Eye
por: Fini, M. Elizabeth, et al.
Publicado: (2020)

Nfia deletion in myeloid cells blocks expansion of myeloid-derived suppressor cells during sepsis
por: Dai, Jun, et al.
Publicado: (2017)

Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19
por: Rowlands, Marianna, et al.
Publicado: (2021)

Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
por: Ozbay Kurt, Feyza Gul, et al.
Publicado: (2023)

Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
por: Wang, Shifen, et al.
Publicado: (2023)

Inactivation of tumor suppressor gene Clusterin leads to hyperactivation of TAK1-NF-κB signaling axis in lung cancer cells and denotes a therapeutic opportunity
por: Chen, Zhipeng, et al.
Publicado: (2020)

Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor
por: Amada, Kohei, et al.
Publicado: (2023)

Proapoptotic role of nuclear clusterin in brain
por: Kim, Nayoung, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vegqjt51e7s9jpg16uggkjkkhv